|
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
1 |
[GO] |
2023―Sep―21 |
A Bioinformatic Analysis: Previous allergen exposure may support anti- SARS-CoV-2 immune response |
Işil Kutluturk Karagoz, Mucahit Kaya, René Rückert, Nazli Bozman, Vildan Kaya, Halim Bayram, Mustafa Yildirim |
2 |
[GO] |
2023―Sep―20 |
Computational analysis of substrate recognition of Sars-Cov-2 Mpro main protease |
Hilal Sena Tasci, Ebru Akkus, Muslum Yildiz, Abdulkadir Kocak |
3 |
[GO] |
2023―Sep―09 |
COMPUTATIONAL ANALYSIS OF THE INTERACTIONS BETWEEN EBSELEN AND DERIVATIVES WITH THE ACTIVE SITE OF THE MAIN PROTEASE FROM SARS-COV-2 |
Guilherme Schmitt Rieder, Pablo Andrei Nogara, Folorunsho Bright Omage, Tâmie Duarte, Cristiane Lenz Dalla Corte, João Batista Teixeira da Rocha |
4 |
[GO] |
2023―Aug―16 |
A Deep-SIQRV Epidemic Model for COVID-19 to Access the Impact of Prevention and Control Measures |
Aakansha Gupta, Rahul Katarya |
5 |
[GO] |
2023―Jul―19 |
ReGen-DTI: A novel generative drug target interaction model for predicting potential drug candidates against SARS-COV2 |
Kaushik Bhargav Sivangi, Santhosh Amilpur, Chandra Mohan Dasari |
6 |
[GO] |
2023―Jul―07 |
Role of Molecular Mimicry in the SARS-CoV-2-Human Interactome for Pathogenesis of Cardiovascular Disease: An Update to ImitateDB |
Sonali Tayal, Sonika Bhatnagar |
7 |
[GO] |
2023―Jul―06 |
Terpenoid phytocompounds from mangrove plant Xylocarpus moluccensis as possible inhibitors against SARS-CoV-2: In silico strategy |
Kiran Bharat Lokhande, Arti Kale, Bhagyashree Shahakar, Ashish Shrivastava, Neelu Nawani, K. Venkateswara Swamy, et al. (+2) Ashutosh Singh, Sarika Vishnu Pawar |
8 |
[GO] |
2023―Mai―24 |
Inflammation Inhibitory Activity of Green Tea, Soybean, and Guava Extracts During Sars-Cov-2 Infection Through TNF Protein in Cytokine Storm |
Didik Priyandoko, Wahyu Widowati, Hanna Sari Widya Kusuma, Ervi Afifah, Cahyaning Rizki Wijayanti, Rizal Rizal, et al. (+4) Ika Adhani Sholihah, Galuh Wening Permatasari, Anggia Ramadhani, Didik Huswo Utomo |
9 |
[GO] |
2023―Jan―05 |
QM/MM study of N501 involved intermolecular interaction between SARS-CoV-2 receptor binding domain and antibody of human origin |
Yuemin Liu, Hana F. Sulaiman, Bruce R. Johnson, Rulong Ma, Yunxiang Gao, Harshica Fernando, et al. (+5) Ananda Amarasekara, Andrea Ashley-Oyewole, Huajun Fan, Heaven N. Ingram, James M. Briggs |
10 |
[GO] |
2023―Jan―03 |
Extraction of Knowledge Graph of Covid-19 Through Mining of Unstructured Biomedical Corpora |
Sudhakaran Gajendran, D Manjula, Vijayan Sugumaran, R Hema |
11 |
[GO] |
2022―Sep―07 |
Dual Computational and Biological Assessment of Some Promising Nucleoside Analogs against the COVID-19-Omicron Variant |
Mohnad Abdalla, Amgad M. Rabie |
12 |
[GO] |
2022―Aug―18 |
Exploiting reverse vaccinology approach for the design of a multiepitope subunit vaccine against the major SARS-CoV-2 variants |
Daniel Melo de Oliveira Campos, Maria Karolaynne da Silva, Emmanuel Duarte Barbosa, Chiuan Yee Leow, Umberto Laino Fulco, Jonas Ivan Nobre Oliveira |
13 |
[GO] |
2022―Jun―28 |
A computational essential dynamics approach to investigate structural influences of ligand binding on Papain like protease from SARS-CoV-2 |
Ekampreet Singh, Rajat Kumar Jha, Rameez Jabeer Khan, Ankit Kumar, Monika Jain, Jayaraman Muthukumaran, Amit Kumar Singh |
14 |
[GO] |
2022―Mai―14 |
Interaction of the New Inhibitor Paxlovid (PF-07321332) and Ivermectin With the Monomer of the Main Protease SARS-CoV-2: A Volumetric Study Based on Molecular Dynamics, Elastic Networks, Classical Thermodynamics and SPT |
Ysaias José Alvarado, Yosmari Olivarez, Carla Lossada, Joan Vera-Villalobos, José Luis Paz, Eddy Vera, et al. (+6) Marcos Loroño, Alejandro Vivas, Fernando Javier Torres, Laura N. Jeffreys, María Laura Hurtado-León, Lenin González-Paz |
15 |
[GO] |
2022―Mai―11 |
A multilevel approach for screening natural compounds as an antiviral agent for COVID-19 |
Mahdi Vasighi, Julia Romanova, Miroslava Nedyalkova |
16 |
[GO] |
2022―Apr―30 |
A new approach for determining SARS-CoV-2 epitopes using machine learning-based in silico methods |
Pınar Cihan, Zeynep Banu Ozger |
17 |
[GO] |
2022―Apr―29 |
Computational study and design of effective siRNAs to silence structural proteins associated genes of Indian SARS-CoV-2 strains |
Premnath Madanagopal, Harshini Muthukumar, Kothai Thiruvengadam |
18 |
[GO] |
2022―Apr―09 |
A Composite Ranking of Risk Factors for COVID-19 Time-To-Event Data from a Turkish Cohort |
Ayse Ulgen, Sirin Cetin, Meryem Cetin, Hakan Sivgin, Wentian Li |
19 |
[GO] |
2022―Apr―06 |
Mathematical modeling and analysis of the SARS-Cov-2 disease with reinfection |
Asghar Atifa, Muhammad Altaf Khan, Kulpash Iskakova, Fuad S. Al-Duais, Irshad Ahmad |
20 |
[GO] |
2022―Mrz―28 |
SARS-CoV-2 3CLpro whole human proteome cleavage prediction and enrichment/depletion analysis |
Lucas Prescott |
21 |
[GO] |
2022―Mrz―23 |
Glycosylation is key for enhancing drug recognition into spike glycoprotein of SARS-CoV-2 |
Georcki Ropón-Palacios, Jhon Pérez-Silva, Ricardo Rojas-Humpire, Gustavo E. Olivos-Ramírez, Manuel Chenet-Zuta, Victor Cornejo-Villanueva, et al. (+5) Sheyla Carmen-Sifuentes, Kewin Otazu, Yaritza L. Ramirez-Díaz, Karolyn Vega Chozo, Ihosvany Camps |
22 |
[GO] |
2022―Feb―26 |
Design and various in silico studies of the novel curcumin derivatives as potential candidates against COVID-19 -associated main enzymes |
Hakan Alici, Hakan Tahtaci, Kadir Demir |
23 |
[GO] |
2022―Feb―26 |
Machine learning prediction of 3CLpro SARS-CoV-2 docking scores |
Lukas Bucinsky, Dušan Bortňák, Marián Gall, Ján Matúška, Viktor Milata, Michal Pitoňák, et al. (+3) Marek Štekláč, Daniel Végh, Dávid Zajaček |
24 |
[GO] |
2022―Feb―19 |
A Global Report on the Dynamics of COVID-19 with Quarantine and Hospitalization: A Fractional Order Model with Non-Local Kernel |
Zubair Ahmad, Sherif A. El-Kafrawy, Thamir A. Alandijany, Francesco Giannino, Ahmed A. Mirza, Mai M. El-Daly, et al. (+4) Arwa A. Faizo, Leena H. Bajrai, Mohammad Amjad Kamal, Esam I. Azhar |
25 |
[GO] |
2021―Dez―01 |
Molecular dynamic simulation analysis of SARS-CoV-2 spike mutations and evaluation of ACE2 from pets and wild animals for infection risk |
Ping Chen, Jingfang Wang, Xintian Xu, Yuping Li, Yan Zhu, Xuan Li, et al. (+2) Ming Li, Pei Hao |
26 |
[GO] |
2021―Nov―20 |
SARS-CoV-2: Can sunlight exposure reduce the risk of developing severe consequences of COVID-19? |
Jibran Sualeh Muhammad, Ruqaiyyah Siddiqui, Naveed Ahmed Khan |
27 |
[GO] |
2021―Nov―02 |
Comprehensive analyses of bioinformatics applications in the fight against COVID-19 pandemic |
Lifei Ma, Huiyang Li, Jinping Lan, Xiuqing Hao, Huiying Liu, Xiaoman Wang, Yong Huang |
28 |
[GO] |
2021―Okt―26 |
Polymorphic landscape of SARS-CoV-2 genomes isolated from Indian population in 2020 demonstrates rapid evolution in ORF3a, ORF8, nucleocapsid phosphoprotein and spike glycoprotein |
Archana Pal, Shefali Dobhal, Kishore Kumar Dey, Anish Kumar Sharma, Vivek Savani, Vishal Singh Negi |
29 |
[GO] |
2021―Sep―02 |
Potential Achilles heels of SARS-CoV-2 are best displayed by the base order-dependent component of RNA folding energy |
Chiyu Zhang, Donald R. Forsdyke |
30 |
[GO] |
2021―Jul―30 |
Modelling the spread of covid-19 in the capital of Brazil using numerical solution and cellular automata |
André Luís Brasil Cavalcante, Lucas Parreira de Faria Borges, Moisés Antônio da Costa Lemos, Márcio Muniz de Farias, Hervaldo Sampaio Carvalho |
31 |
[GO] |
2021―Jul―05 |
Efficient Machine Learning Model for Predicting Drug-Target Interactions with Case Study for Covid-19 |
Heba El-Behery, Abdel-Fattah Attia, Nawal El-Feshawy, Hanaa Torkey |
32 |
[GO] |
2021―Jun―19 |
A computational analysis of molecular evolution for virulence genes of zoonotic novel coronavirus (COVID-19) |
Priya Kumari, Raju Poddar |
33 |
[GO] |
2021―Jun―18 |
Molecular insight into the genomic variation of SARS-CoV-2 strains from current outbreak |
Avizit Das, Sarah Khurshid, Aleya Ferdausi, Eshita Sadhak Nipu, Amit Das, Fee Faysal Ahmed |
34 |
[GO] |
2021―Mai―06 |
Designing Potential siRNA Molecule for the Nucleocapsid(N) Gene Silencing of Different SARS-CoV-2 Strains of Bangladesh: Computational Approach |
Syed Shahariar Bappy, Abu Zaffar Shibly, Sorna Sultana, A.K.M. Mohiuddin, Yearul Kabir |
35 |
[GO] |
2021―Mrz―29 |
Exploring the effectiveness of the TSR-based protein 3-D structural comparison method for protein clustering, and structural motif identification and discovery of protein kinases, hydrolase, and SARS-CoV-2’s protein via the application of amino acid grouping |
Titli Sarkar, Vijay V. Raghavan, Feng Chen, Andrew Riley, Sophia Zhou, Wu Xu |
36 |
[GO] |
2021―Feb―21 |
Docking-based virtual screening studies aiming at the covalent inhibition of SARS-CoV-2 MPro by targeting the cysteine 145 |
Laurent Soulère, Thibaut Barbier, Yves Queneau |
37 |
[GO] |
2020―Nov―05 |
Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism |
Md. Sorwer Alam Parvez, Mohammad Mahfujur Rahman, Md. Niaz Morshed, Dolilur Rahman, Saeed Anwar, Mohammad Jakir Hosen |
38 |
[GO] |
2020―Okt―23 |
Interaction of small molecules with the SARS-CoV-2 main protease in silico and in vitro validation of potential lead compounds using an enzyme-linked immunosorbent assay |
Eleni Pitsillou, Julia Liang, Chris Karagiannis, Katherine Ververis, Kevion K. Darmawan, Ken Ng, et al. (+2) Andrew Hung, Tom C. Karagiannis |
39 |
[GO] |
2020―Sep―13 |
Identification of novel human USP2 inhibitor and its putative role in treatment of COVID-19 by inhibiting SARS-CoV-2 papain-like (PLpro) protease |
Muhammad Usman Mirza, Sarfraz Ahmad, Iskandar Abdullah, Matheus Froeyen |
40 |
[GO] |
2020―Sep―06 |
Site mapping and small molecule blind docking reveal a possible target site on the SARS-CoV-2 main protease dimer interface |
Julia Liang, Chris Karagiannis, Eleni Pitsillou, Kevion K. Darmawan, Ken Ng, Andrew Hung, Tom C. Karagiannis |
41 |
[GO] |
2020―Aug―01 |
An in-silico approach to study the possible interactions of miRNA between human and SARS-CoV2 |
Abhijit Sarma, Homen Phukan, Neha Halder, Madathiparambil Gopalakrishnan Madanan |
42 |
[GO] |
2020―Jul―31 |
Repurposing approved Drugs as potential Inhibitors of 3CL-protease of SARS-CoV-2: Virtual screening and Structure Based Drug Design |
Franz-Josef Meyer-Almes |
43 |
[GO] |
2020―Jun―25 |
Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors |
Alicia Jiménez-Alberto, Rosa María Ribas-Aparicio, Gerardo Aparicio-Ozores, Juan A. Castelán-Vega |
44 |
[GO] |
2020―Mai―28 |
Interaction of the prototypical α-ketoamide inhibitor with the SARS-CoV-2 main protease active site in silico: Molecular dynamic simulations highlight the stability of the ligand-protein complex |
Julia Liang, Eleni Pitsillou, Chris Karagiannis, Kevion K Darmawan, Ken Ng, Andrew Hung, Tom C. Karagiannis |